Julian Topaly
- Hematology top 2%
- Genetics top 5%
- Molecular Biology
- Oncology
- Rheumatology top 10%
- Co-authors
- Stefan FrüehaufAnthony D. HoMarlon R. VeldwijkW. Jens ZellerStephanie LaufsFrederik WenzHartmut GoldschmidtUlrich R. Hengge
- Topics
- Chronic Myeloid Leukemia Treatments (15 papers)Chronic Lymphocytic Leukemia Research (10 papers)Eosinophilic Disorders and Syndromes (10 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Julian Topaly
30 papers receiving 828 citations
Peers
Comparison fields: 5 of 76
- Hematology 522
- Genetics 291
- Molecular Biology 240
- Oncology 194
- Rheumatology 163
Countries citing papers authored by Julian Topaly
This map shows the geographic impact of Julian Topaly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julian Topaly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julian Topaly more than expected).
Fields of papers citing papers by Julian Topaly
This network shows the impact of papers produced by Julian Topaly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julian Topaly. The network helps show where Julian Topaly may publish in the future.
Co-authorship network of co-authors of Julian Topaly
This figure shows the co-authorship network connecting the top 25 collaborators of Julian Topaly. A scholar is included among the top collaborators of Julian Topaly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julian Topaly. Julian Topaly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 23 | |
| 5 | 50 | |
| 6 | 6 | |
| 7 | 6 | |
| 8 | 99 | |
| 9 | 43 | |
| 10 | 36 | |
| 11 | Combination treatment of imatinib-sensitive and -resistant BCR-ABL-positive CML cells with imatinib and farnesyltransferase inhibitors. | 15 |
| 12 | 78 | |
| 13 | 11 | |
| 14 | 12 | |
| 15 | 98 | |
| 16 | 30 | |
| 17 | 27 | |
| 18 | 42 | |
| 19 | 28 | |
| 20 | 32 |
About Julian Topaly
Julian Topaly is a scholar working on Hematology, Genetics and Rheumatology, having authored 31 papers that have together received 848 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (15 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Eosinophilic Disorders and Syndromes (10 papers). The work is most often cited by research in Hematology (522 citations), Genetics (291 citations) and Rheumatology (163 citations). Julian Topaly has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Stefan Früehauf, Anthony D. Ho, Marlon R. Veldwijk, W. Jens Zeller, W. Jens Zeller, Stephanie Laufs, Frederik Wenz, Hartmut Goldschmidt, Ulrich R. Hengge and Aleksandar Radujkovic. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.